Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL375842 | 1.00 | ALDH1A1 (0.30) | ALDH1A1HSD17B10 | |
| SCHEMBL135065 | 0.96 | — | — | |
| SCHEMBL2154851 | 0.65 | ALDH1A1 (0.36) | ALDH1A1 | |
| SCHEMBL138530 | 0.59 | — | — | |
| SCHEMBL18430746 | 0.59 | — | — | |
| SCHEMBL31178563 | 0.59 | — | — | |
| SCHEMBL12079166 | 0.56 | ALDH1A1 (0.36) | ALDH1A1HSD17B10 | |
| SCHEMBL5924608 | 0.56 | — | — | |
| SCHEMBL18636380 | 0.56 | ALDH1A1 (0.36) | ALDH1A1HSD17B10 | |
| SCHEMBL1977943 | 0.56 | ALDH1A1 (0.36) | ALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2314566-B1 | Process for the functionalization of biological molecules | COMMISSARIAT L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2018-01-24 | — | — | EP | disclosed |
| EP-2408792-B1 | NOVEL BIFUNCTIONAL MOLECULES COMPRISING A CYCLOALKYNE OR HETEROCYCLOALKYNE GROUP AND A REDOX GROUP | COMMISSARIAT L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2014-08-20 | — | — | EP | disclosed |
| EP-2408793-B1 | METHOD FOR SURFACE FUNCTIONALISATION BY DISUBSTITUTED ALKYNES | COMMISSARIAT L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2014-07-23 | — | — | EP | disclosed |
| US-8653291-B2 | Method for surface functionalization by disubstituted alkynes | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2014-02-18 | — | — | US | disclosed |
| US-8592619-B2 | Bifunctional molecules comprising a cycloalkyne or heterocycloalkyne group and a redox group | Commissariat a L'Energie Atomique et aux Enerigies Alternatives (FR) | 2013-11-26 | — | — | US | disclosed |
| US-8541604-B2 | Process for the functionalization of biological molecules | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2013-09-24 | — | — | US | disclosed |
| US-20120095247-A1 | METHOD FOR SURFACE FUNCTIONALIZATION BY DISUBSTITUTED ALKYNES | COMMISSARIAT A L'ENERGIE AUTOMIQUE ET AUX ENE ALT (FR) | 2012-04-19 | — | — | US | disclosed |
| US-20120037871-A1 | NOVEL BIFUNCTIONAL MOLECULES COMPRISING A CYCLOALKYNE OR HETEROCYCLOALKYNE GROUP AND A REDOX GROUP | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2012-02-16 | — | — | US | disclosed |
| EP-2408792-A1 | NOVEL BIFUNCTIONAL MOLECULES COMPRISING A CYCLOALKYNE OR HETEROCYCLOALKYNE GROUP AND A REDOX GROUP | Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR) | 2012-01-25 | — | — | EP | disclosed |
| US-20110118484-A1 | PROCESS FOR THE FUNCTIONALIZATION OF BIOLOGICAL MOLECULES | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2011-05-19 | — | — | US | disclosed |
| EP-2314566-A1 | Process for the functionalization of biological molecules | Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR) | 2011-04-27 | — | — | EP | disclosed |
| WO-2010106245-A1 | NOVEL BIFUNCTIONAL MOLECULES COMPRISING A CYCLOALKYNE OR HETEROCYCLOALKYNE GROUP AND A REDOX GROUP | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2010-09-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120037871-A1 | NOVEL BIFUNCTIONAL MOLECULES COMPRISING A CYCLOALKYNE OR HETEROCYCLOALKYNE GROUP AND A REDOX GROUP | CBR3, CBR1, CYBB | ALDH1A1 244/4885HSD17B10 308/4885 |
| US-20110118484-A1 | PROCESS FOR THE FUNCTIONALIZATION OF BIOLOGICAL MOLECULES | POLRMT, DNASE1, POLM | ALDH1A1 597/4885HSD17B10 2271/4885 |
| US-20120095247-A1 | METHOD FOR SURFACE FUNCTIONALIZATION BY DISUBSTITUTED ALKYNES | F12, CYP1A1, ADGRF1 | ALDH1A1 72/4885HSD17B10 815/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.